Encyclopedia of Clinical Trials Now Available
Wiley Encyclopedia of Clinical Trials
NOW AVAILABLE
From helping regulatory authorities to decide whether to approve a drug for use in their country to assisting health professionals making decisions about prescribing treatment, clinical trials are critical when it comes to determining the safety and effectiveness of a drug or treatment and discovering any side effects. For those working in the medical community therefore, it is vital that they have quick and easy access to the most advanced and up-to-date information available, allowing them to see how a treatment works, how it compares to other therapies and what choices are best for their patients best. But, where to look?
The only major reference work devoted to this crucial area of medical research, the Wiley Encyclopedia of Clinical Trials is a unique and world-class compendium of basic concepts, methodologies and applications in clinical trials. Divided into four volumes, available in book-format or online at www.interscience.wiley.com/reference/wect, and including more than 1,200 A-Z entries, this reliable, up-to-date and comprehensive work covers all aspects of the trial from basic statistical concepts to design and analysis, genetics to regulatory issues, ethics to safety and toxicity. Special prominence is placed on current and emerging clinical issues, newly developed statistical methods, and reviews of statistical methodologies in various therapeutic surroundings.
Written by 600 of the worlds leading specialists working in corporate, pharmaceutical and academic environments, including Robert J. Gray to Sylvie Chev, Alon Z. Weizer and Chris Stevenson, the Wiley Encyclopedia of Clinical Trials incorporates a wealth of valuable information on a wide range of clinical trials, from cardiovascular to pulmonary, reproductive to urological. Meticulously compiled and unrivalled in breadth and scope, this is a must-have reference tool for anyone working in the field of medical research.
Ralph B. D’Agostino is Professor of Mathematics and Statistics and Executive Director, Graduate Program in Biostatistics at Boston University. He is the lead editor of the journal Statistics in Medicine and author and co-author of many books in biostatistics. Lisa M. Sullivan is Associate Dean for Undergraduate Education and Associate Professor of Biostatistics at Boston University. Joseph M. Massaro is Assistant Professor of Biostatistics, also at Boston University.
Editors-in-Chief: Ralph B. D’Agostino, Lisa M. Sullivan & Joseph M. Massaro
TOPICS COVERED INCLUDE:
- Clinical Data Management
- Clinical Fields
- Device Trials
- Ethical Issues
- Genetics and Genomics
- Methodology/Analysis
- Phase I Study Design
- Phase II Study Design
- Phase III Study Design
- Phase IV Study Design
- Regulatory Issues
- Safety/Toxicity
For a full list of contents, go to: www.interscience.wiley.com/reference/wect
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
